Post-transplantation cyclophosphamide versus low dose ATG FRESENIUS IN GVHD prophylaxiS: Similar graft versus host disease and relapse-free survival

被引：0

作者：

Fernandez Martinez, Cristina ^{[1
]}

Bermudez Rodriguez, Arancha ^{[1
,2
]}

Garcia Avila, Sara ^{[1
]}

Cabero Martinez, Almudena ^{[1
]}

Yanez Sansegundo, Lucrecia ^{[1
]}

Lopez Duarte, Monica ^{[1
]}

Mora Barrios, Joan Manuel ^{[1
]}

Gonzalez Romero, Yolanda ^{[1
]}

Fernandez Luis, Sara ^{[1
]}

Gomez Lamas, David ^{[1
]}

Insunza Gaminde, Andres ^{[1
]}

Romon, Inigo ^{[1
]}

Luis Arroyo, Jose ^{[3
]}

Richard Espiga, Carlos ^{[1
]}

Ocio San Miguel, Enrique Maria ^{[1
,2
]}

Colorado Araujo, Mercedes ^{[1
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Inst Formac Invest Marques de Valdecilla IDI VAL, Santander, Spain

[2] Univ Cantabria, Santander, Spain

[3] Banco Sangre & Tejidos Cantabria, Santander, Spain

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O119

引用

页码：93 / 94

页数：2

共 50 条

[1] Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)
Fernandez Martinez, Cristina
Bermudez, Arancha
Garcia Avila, Sara
San Pedro, Borja
Cabero Martinez, Almudena
Yanez, Lucrecia
Lopez Duarte, Monica
Colorado, Mercedes
Gonzalez de Villambrosia, Sonia
Manuel Mora, Joan
Gonzalez Romero, Yolanda
Gomez, David
Fenandez Luis, Sara
Ormazabal, Irati
Insunza, Andres
Romon, Inigo
Luis Arroyo, Jose
Conde, Eulogio
Richard, Carlos
[J]. BLOOD, 2018, 132
[2] Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
Salibaaw, Rima M.
Alousia, Amin M.
Pidala, Joseph
Arora, Mukta
Spellman, Stephen R.
Hemmer, Michael T.
Wang, Tao
Abboudg, Camille
Ahmed, Sairah
Antin, Joseph H.
Beitinjanehi, Amer
Buchbinder, David K.
Byrne, Michael
Cahn, Jean-Yves
Choen, Hannah
Hanna, Rabi
HemattiP, Peiman
Kamble, Rammurti T.
Kitkor, Carrie L.
Laughlin, Mary
Lekakis, Lazaros
MacMillan, Margaret L.
Martino, Rodrigo
Mehta, Parinda A.
Nishihori, Taiga
Patel, Sagar S.
Perales, Miguel-Angel
Rangarajan, Hemalatha G.
Ringden, Olov
Rosenthal, Joseph
Savani, Bipin N.
Schultz, Kirk R.
Seo, Sachiko
Teshimaag, Takanori
van der Poela, Marjolein
Verdonck, Leo F.
Weisdorf, Daniel
Wirk, Baldeep
Yared, Jean A.
Schriber, Jeffrey
Champlin, Richard E.
Ciurea, Stefan O.
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 681 - 693
[3] Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis
Tandra, Anand
Metheny, Leland
Yao, David
Caimi, Paolo F.
Brister, Lauren
Cooper, Brenda
Lazarus, Hillard M.
Tomlinson, Ben K.
Malek, Ehsan
Covut, Fahrettin
Pinto, Raisa
deLima, Marcos
[J]. BLOOD, 2016, 128 (22)
[4] Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality
Ormazabal Velez, Irati
Aranzazu Bermudez, Maria
Insunza, Andres
Yanez, Lucrecia
Richard, Carlos
Conde, Eulogio
[J]. BLOOD, 2015, 126 (23)
[5] Post-transplantation cyclophosphamide compared to graft-versus-host disease prophylaxis with ATG in mismatched unrelated donor hematopoietic stem cell transplantation
Soltermann, Yves
Heim, Dominik
Baldomero, Helen
Medinger, Michael
Halter, Jorg P.
Passweg, Jakob P.
Kleber, Martina
[J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 75 - 76
[6] Post-Transplantation CyclophosphamideBased Graft-versus-Host Disease Prophylaxis
Bolanos-Meade, J.
Hamadani, M.
Wu, J.
Al Malki, M. M.
Martens, M. J.
Runaas, L.
Elmariah, H.
Rezvani, A. R.
Gooptu, M.
Larkin, K. T.
Shaffer, B. C.
El Jurdi, N.
Loren, A. W.
Solh, M.
Hall, A. C.
Alousi, A. M.
Jamy, O. H.
Perales, M. -A.
Yao, J. M.
Applegate, K.
Bhatt, A. S.
Kean, L. S.
Efebera, Y. A.
Reshef, R.
Clark, W.
DiFronzo, N. L.
Leifer, E.
Horowitz, M. M.
Jones, R. J.
Holtan, S. G.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2338 - 2348
[7] Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
Mehta, Rohtesh S.
Saliba, Rima M.
Chen, Julianne
Rondon, Gabriela
Hammerstrom, Aimee E.
Alousi, Amin
Qazilbash, Muzaffar
Bashir, Qaiser
Ahmed, Sairah
Popat, Uday
Hosing, Chitra
Khouri, Issa
Shpall, Elizabeth J.
Champlin, Richard E.
Ciurea, Stefan O.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 444 - 455
[8] Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
Mehta, Rohtesh S.
Saliba, Rima M.
Rondon, Gabriela
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Kebriaei, Partow
Khouri, Issa
Nieto, Yago
Oran, Betul
Popat, Uday R.
Qazilbash, Muzaffar H.
Ramdial, Jeremy
Srour, Samer A.
Champlin, Richard E.
Rezvani, Katayoun
Shpall, Elizabeth J.
Alousi, Amin M.
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 695.e1 - 695.e10
[9] Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus
Ashouri, Karam
Fernandez, Eduardo
Ginosyan, Anush
Feliciano, Carissa M.
Hom, Brian
Rodman, Jack
Ali, Amir
Ladha, Abdullah
Woan, Karrune
Tam, Eric
Chaudhary, Preet
Yaghmour, George
[J]. TRANSPLANTATION PROCEEDINGS, 2024, 56 (07) : 1 - 7
[10] Orca-Q Demonstrates Favorable Graft-Versus-Host Disease (GvHD) and Relapse-Free Survival With Haploidentical Donors Without Post-Transplant Cyclophosphamide
Srour, Samer A.
Salhotra, Amandeep
Lowsky, Robert
Hoeg, Rasmus T.
Saad, Ayman
Waller, Edmund K.
Pavlova, Anna
McClellan, J. Scott
Fernhoff, Nathaniel B.
Meyer, Everett H.
Abedi, Mehrdad
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S537 - S537

← 1 2 3 4 5 →